Human Vasodilatory Effect of GLP-1
NCT03502083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2018-04-18
Summary
Comprehensive assessment of human vasodilatory effect of GLP-1 in forearm and coronary arteries
Conditions
- Coronary Stenosis
- Type2 Diabetes
- Angina, Stable
Interventions
- DRUG
-
GLP-1 (7-36)Amide
IV infusion
Sponsors & Collaborators
-
Papworth Hospital NHS Foundation Trust
lead OTHER_GOV
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-01
- Primary Completion
- 2017-03-01
- Completion
- 2017-03-01
More Related Trials
-
GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
NCT02577848 ·Status: UNKNOWN ·Phase: NA
-
Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting
NCT02236299 ·Status: UNKNOWN ·Phase: NA
-
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
NCT07073053 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
GLP-1 Loading During Elective Percutaneous Coronary Intervention
NCT02127996 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure
NCT02129179 ·Status: COMPLETED ·Phase: PHASE1
-
GLP-1 and Microvascular Function in Type 2 Diabetes
NCT01740921 ·Status: COMPLETED ·Phase: NA
-
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
NCT00540215 ·Status: COMPLETED ·Phase: NA
-
Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
NCT02846168 ·Status: UNKNOWN
-
Effects of GLP-1 on Chronic Heart Failure
NCT02650596 ·Status: UNKNOWN ·Phase: NA
-
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
NCT01988545 ·Status: UNKNOWN ·Phase: NA
-
Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
NCT02490176 ·Status: UNKNOWN ·Phase: NA
-
GLP-1: Acute Effects on Kidney Function in Healthy Men
NCT01333163 ·Status: COMPLETED ·Phase: NA
-
Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
NCT03129594 ·Status: COMPLETED
-
Cardiovascular Effects of GLP-1 Receptor Activation
NCT03101930 ·Status: COMPLETED ·Phase: PHASE4
-
Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
NCT00923962 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
NCT02042664 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans
NCT06333496 ·Status: COMPLETED ·Phase: NA
-
The Microvascular Function of GLP-1 and Its Analogues
NCT01677104 ·Status: COMPLETED ·Phase: NA
-
Liraglutide and Heart Failure in Type 2 Diabetes
NCT01425580 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
NCT04034524 ·Status: UNKNOWN
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
NCT02403284 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
NCT01021865 ·Status: COMPLETED
-
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
NCT06818292 ·Status: COMPLETED ·Phase: NA